Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BURP trial in adults with inability to belch
NL-OMON23976Recruiting
- Start
- Aug 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of neuronox in Retrograde Cricopharyngeal Dysfunction (R-CPD), sponsored by None. Primary endpoint: Upper esophageal sphincter relaxation response to esophageal distention. Started Aug 2019; status: recruiting.
02
Drugs
neuronox
03
Conditions
Retrograde Cricopharyngeal Dysfunction (R-CPD)
Beyond the preview
Go deeper on NL-OMON23976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23976.